GLAXO GROUP LIMITED
Patent Owner
Stats
- 536 US PATENTS IN FORCE
- 18 US APPLICATIONS PENDING
- Jan 09, 2018 most recent publication
Details
- 536 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 28,457 Total Citation Count
- Apr 24, 1978 Earliest Filing
- 1,492 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
| Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2016/0317,398 DENTIFRICE COMPOSITION COMPRISING SPHERICAL FUSED ALUMINUM OXIDE PARTICLESDec 17, 14Nov 03, 16[A61K, A61Q]
2016/0228,341 Dentifrice Composition Comprising Sintered HydroxyapatiteSep 24, 14Aug 11, 16[A61K, A61Q]
2016/0151,588 Pharmaceutical Metered Dose Inhaler and Methods Relating TheretoFeb 05, 16Jun 02, 16[A61K, A61M]
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9850307 Nucleic acids encoding immunoglobulins that bind TGF-beta receptor IISep 02, 15Dec 26, 17[C12N, C07K]
9795561 Combination of umeclidinium, fluticasone propionate and salmeterol xinafoate for use in the treatment of inflammatory or respiratory tract diseasesDec 17, 13Oct 24, 17[A61J, A61K]
9750726 Combinations of a muscarinic receptor antagonist and a beta-2 adrenoreceptor agonistDec 16, 15Sep 05, 17[A61K, A01N, B65D]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2016/0069,826 Sample Plate for An X-Ray Powder Diffraction ApparatusAbandonedNov 05, 15Mar 10, 16[G01N]
2015/0342,897 POLYPEPTIDE LOADED POCA NANOPARTICLES FOR ORAL ADMINISTRATIONAbandonedMay 16, 13Dec 03, 15[A61K]
2015/0306,058 COMPOSITION COMPRISING A SINGLE VARIABLE DOMAIN AND CAMOSTAT MESYLATE (CM)AbandonedAug 21, 13Oct 29, 15[A61K]
2015/0251,148 Container System for Mixing and Dispensing a DrinkAbandonedNov 01, 13Sep 10, 15[A23L, A47J, B01F]
2015/0210,767 STABLE ANTI-TNFR1 POLYPEPTIDES, ANTIBODY VARIABLE DOMAINS & ANTAGONISTSAbandonedApr 09, 15Jul 30, 15[C07K]
2015/0209,319 COMPOSITIONS COMPRISING AN ANTIBODY AND CAMOSTAT MESYLATE (CM)AbandonedAug 21, 13Jul 30, 15[A61K]
2015/0203,851 INHIBITORS OF BROMODOMAIN-CONTAINING PROTEIN PCAF FOR THE TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISEASES OR FOR THE TREATMENT OF CANCERAbandonedSep 04, 13Jul 23, 15[C12N, G01N]
2015/0093,440 AGGREGATE NANOPARTICULATE MEDICAMENT FORMULATIONS, MANUFACTURE AND USE THEREOFAbandonedOct 13, 11Apr 02, 15[A61K]
2015/0017,671 METHODS FOR DETECTING LP-PLA2 ACTIVITY AND INHIBITION OF LP-PLA2 ACTIVITYAbandonedSep 26, 14Jan 15, 15[C12Q]
2014/0335,083 METHODS OF TREATMENT AND PREVENTION OF EYE DISEASESAbandonedNov 30, 12Nov 13, 14[A61K, C07D]
2014/0311,977 USE OF ORGANIC SOLVENT NANOFILTRATION AND LIQUID-LIQUID CHROMATOGRAPHY FOR THE RECOVERY OF PHARMACEUTICAL PRODUCTSAbandonedNov 20, 12Oct 23, 14[B01D]
Top Inventors for This Owner
| Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.
